4TH Central European Biomedical Congress

4
5
days
1
9
hours
2
8
minutes
4
8
seconds

Welcome
address

Dear Friends and Colleagues,

We closely monitored the development related to COVID-19 and in the light of the update, we decided to postpone the 4th Central European Biomedical Congress (CEBC) to 7-9 June 2021. The motto of the 4th CEBC Virtual remains valid and reads: The Impact of bioinformatics and omics on biology and medicine.

This congress is jointly organized by the Maj Institute of Pharmacology Polish Academy of Sciences and the Faculty of Medicine, Jagiellonian University Medical College.

Through a series of virtual plenary lectures, oral sessions, poster sessions and workshops, industry-sponsored symposia and exhibitions, 4th CEBC will provide new information about use of the latest advances in biological and medical sciences, novel technologies such as “multi-omics”, mobile applications, augmented reality and neural networks.

The Congress also will promote outstanding opportunities for junior scientists to present research and interact with leaders in the field, including awardees of European Research Council grants.

Adopting a highly multidisciplinary approach, the Congress aims to draw participation of clinicians, pharmacologists, biologists, bioinformaticians and chemists, sharing the common goal to promote international scientific cooperation and to exchange of ideas and concepts.

We are convinced the Congress will be a memorable event.

Once again we would like to cordially invite to join us at the 4th CEBC, and we look forward to welcoming you in 2021!

We hope everybody stays safe and look forward to seeing you on the new event date!

Best regards,

On behalf of the Organizing Committee

Małgorzata Filip

Maj Institute of Pharmacology
Polish Academy of Sciences
Krakow

flag

Joanna Pera

Faculty of Medicine
Jagiellonian University, College Medicine
Krakow

flag

About the Event

CEBC 2021 is dedicated to:

clinicians, physicians, pharmacologists, biologists, bioinformaticians and chemists.

Plenary
speakers

  • flag
    Professor, David E. Nichols, PhD

    Professor, David E. Nichols, PhD

    Purdue University College of Pharmacy,
    West Lafayette, LA, USA

    Plenary lecture:
    Psychedelic Research in the 21st Century

    Professor, David E. Nichols, PhD

    David E. Nichols, PhD is currently an Adjunct Professor in the Eshelman School of Pharmacy at the University of North Carolina, Chapel Hill, NC.  He is a Distinguished Professor Emeritus at the Purdue University College of Pharmacy and was the Robert C. and Charlotte P. Anderson Distinguished Chair in Pharmacology, where he carried out teaching and research for 38 years prior to his retirement in 2012.  In 2004 he was named the Irvine H. Page Lecturer by the International Society for Serotonin Research, he received the first Purdue Provost’s Outstanding Graduate Mentor award in 2006, and was named a Distinguished Alumnus by the University of Iowa College of Pharmacy in 2012.  He began studying psychedelics in 1969 while a graduate student and continued that research throughout his entire professional career, being one of only a few investigators able to research psychedelics after they were scheduled.  In 1993 he founded the Heffter Research Institute (HRI), which funded the first rigorous clinical studies of psychedelics in humans after a nearly 40-year moratorium and served as its president for more than 25 years. HRI funded the groundbreaking Phase I and II studies of psilocybin for the treatment of depression, as well as substance use disorders. Dr. Nichols also synthesized the DMT used by Dr. Rick Strassman in his human studies, the MDMA that MAPS used for their Phase I and II clinical trials for PTSD, and the psilocybin used by several investigators for human clinical studies including the Phase I and II trials conducted at Johns Hopkins University by Roland Griffiths and his colleagues. He is considered the world’s leading expert on the chemistry of psychedelics. Dr. Nichols, although officially retired, remains active in the field through consulting and collaborations with several academic and pharmaceutical organizations and continues to publish scientific papers.

  • flag
    Professor, Francesco Pavone, PhD

    Professor, Francesco Pavone, PhD

    European Laboratory for Non Linear Spectroscopy
    and Department of Physics,
    University of Florence, Italy

    Inaugural lecture:
    Human brain optical mapping

    Professor, Francesco Pavone, PhD

  • flag
    Professor, Francesco Battaglia, PhD

    Professor, Francesco Battaglia, PhD

    the Donders Institute for Brain, Cognition and Behaviour,
    Radboud University, Nijmegen, The Netherlands

    Plenary lecture:
    The lifetime of memories: processing and reprocessing of information in the brain

    Professor, Francesco Battaglia, PhD

  • flag
    Professor, Jacek R. Wiśniewski, PhD

    Professor, Jacek R. Wiśniewski, PhD

    Research Department Proteomics and Signal Transduction,
    Max Planck Institute of Biochemistry, Martinsried, Germany

    Plenary lecture:
    Large scale proteomics for understanding biological systems

    Professor, Jacek R. Wiśniewski, PhD

Speakers

  • flag
    Natalia Alenina

    Natalia Alenina

    Max Delbruck Center for Molecular Medicine,
    Berlin, Germany

    Natalia Alenina

  • flag
    Marian Bubak

    Marian Bubak

    Sano Centre for Computational Medicine, Krakow and AGH University of Science and Technology,
    Krakow, Poland

    Marian Bubak

  • flag
    Lucia Caffino

    Lucia Caffino

    Università degli Studi di Milano,
    Milano, Italy

    Lucia Caffino

  • flag
    Francesca Calabrese

    Francesca Calabrese

    Associate Professor at the Department of Pharmacological and Biomolecular Sciences,
    University of Milan, Italy

    Francesca Calabrese

    Francesca Calabrese is currently Associate Professor at the Department of Pharmacological and Biomolecular Sciences (University of Milan). She got her degree in Pharmaceutical Chemistry and Technology at the University of Milan in 2003. In the same University, she got her PhD in Pharmacotoxicological, Pharmacognostic Sciences and Pharmacological Biotechnologies at the Faculty of Pharmacy in 2007 discussing a thesis entitled ‘Involvement of the neurotrophin BDNF in the mechanism of action of antidepressant drugs and in animal models of mood disorders’. In 2007 she was awarded the fellowship ‘Borsa di perfezionamento all’estero’ in order to develop a project at the Zentralinstitut für Seelische Gesundheit-Univ Heidelberg, (Mannheim, Germany). Her scientific interest is focused on the study of psychiatric disorders pathogenesis. The experimental approach is intended to investigate the systems that can contribute to the development of such diseases through the use of animal models (genetic and environmental), as well as to characterize the mechanism of action of psychotropic drugs. She is principal investigator of 8 competitive grants (national and international). She is co-author of 67 peer-reviewed papers, 48 as first, second or last author (H-index= 30, Number of citations= 2673) She attended several international meetings and presented several posters and oral communications on her research. During these years, she received fellowship awards, travel grants and poster prizes.

  • flag
    Anna Ceglarek

    Anna Ceglarek

    Jagiellonian University,
    Krakow, Poland

    Anna Ceglarek

  • flag
    Adrian Chrobak

    Adrian Chrobak

    Jagiellonian University Medical College,
    Krakow, Poland

    Adrian Chrobak

  • flag
    Giulia Costa

    Giulia Costa

    University of Cagliari,
    Cagliari, Italy

    Giulia Costa

  • flag
    Wiesław J. Cubala

    Wiesław J. Cubala

    Medical University of Gdansk,
    Gdansk, Poland

    Wiesław J. Cubala

    Wiesław Jerzy Cubała is the Head of the Department of Psychiatry at the Medical University of Gdansk, Poland. His research interests focus on the psychopharmacology of anxiety and mood disorders with a particular interest in ketamine/esketamine use in depression as well as the serotonin-1A receptor function in major depression and panic disorder. Prof. Cubała runs a project on monoaminergic, proinflammatory activity measures and cognitive performance in mood and anxiety disorders. Currently, he is focussed on the study of ketamine use in major depression and bipolar depression, as well as clozapine use in treatment-resistant bipolar depression with a particular focus on suicidality and the rapid-cycling course of the disorders. Moreover, his research team develops screening tools for people with epilepsy suffering from mental disorders. Prof. Cubała is involved in training initiatives in postgraduate education in psychiatry and cognitive-behavioural therapy, including the development of the treatment guidelines for mood and anxiety disorders for psychiatrists and general practitioners. He is devoted to teaching both the clinical and research aspects of psychopharmacology.

  • flag
    Kathryn A. Cunningham

    Kathryn A. Cunningham

    University of Texas Medical Branch,
    Galveston, USA

    Kathryn A. Cunningham

  • flag
    Bogdan Draganski

    Bogdan Draganski

    University of Lausanne,
    Lausanne, Switzerland

    Bogdan Draganski

    Professor Bogdan Draganski, native Bulgarian, is Consultant Neurologist at the Department of Clinical Neurosciences, University Hospital of Lausanne, Switzerland, Director of the neuroimaging laboratory LREN and of the Departmental MRI platform. After qualifying in Clinical Neurology in Germany he spent time working on computational anatomy research in neurodegenerative and movement disorders at the Institute of Neurology, UCL London, UK followed by research at the Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig Germany.

    I was trained in state-of-the-art magnetic resonance imaging techniques to investigate brain anatomy correlates of neurological disorders. Using methods that I and colleagues developed, I will enrich these models with features from non-invasive magnetic resonance imaging (MRI) sensitive to brains’ myelin, iron and tissue free water content, to then test for systematic differences across cortico-striatal circuits and along spatial gradients within a given node of the studied networks. I pioneered computational anatomy research in use- dependent brain plasticity, developed and established new methods to understand the underlying biological phenomenon.

  • flag
    Dominika Dudek

    Dominika Dudek

    Jagiellonian University Medical College,
    Krakow, Poland

    Dominika Dudek

    Head of the Department of Psychiatry at the Jagiellonian University Medical College. President Elect of the Polish Psychiatric Association, member of the Scientific Council of the Institute of Psychiatry and Neurology. Organizer of the annual Pharmacotherapy, Psychotherapy and Rehabilitation of Affective Disorders Conference (2017 – XXII edition). Chairwoman of the State Examination Commission in Krakow for psychiatry, member of the Local Organizing Committee of EPA 2019 Warsaw. Editor-in-chief of the journal Psychiatria Polska. Author and co-author of many publications about depression, bipolar disorders. Editor and co-author of several books on psychiatric issues.

  • flag
    Gordana Nedic Erjavec

    Gordana Nedic Erjavec

    Ruđjer Bošković Institute,
    Zagreb, Croatia

    Gordana Nedic Erjavec

  • flag
    Giuseppe Giannotti

    Giuseppe Giannotti

    University of Colorado Denver,
    Aurora, CO, USA

    Giuseppe Giannotti

  • flag
    Maciej Giefing

    Maciej Giefing

    Institute of Human Genetics Polish Academy of Sciences,
    Poznan, Poland

    Maciej Giefing

  • flag
    Andreas Grabrucker

    Andreas Grabrucker

    University of Limerick
    Limerick, Germany

    Andreas Grabrucker

    Dr. Grabrucker received his MSc in Biology from the Technical University of Munich (TUM), Germany, and his PhD in Molecular Medicine from Ulm University, Germany. He continued his research in the United States at Stanford University, Stanford School of Medicine. From 2011 to 2016, he was tenure-track Assist. Professor and Executive Director of the Neurocenter of Ulm University. In 2017, he joined the Department of Biological Sciences, at the University of Limerick, Ireland and the Bernal Research Institute. He is now Associate Professor and Cluster lead of the Bio Materials Cluster of the Bernal Institute, a cluster with 20 faculty members and about 60 PhD students and Postdocs. He was also awarded a guest professorship at the University of Modena and Reggio Emilia, Italy, in 2019. Dr. Grabrucker’s major research focus is translational neuroscience in the area of Autism Spectrum Disorders, where he generates model systems to understand neurobiological processes of brain development and function. Since 2009, he has published 13 book chapters and over 58 articles in peer reviewed journals, that were cited over 2900 times. He is also author of the popular science book “Eco-Neurobiology and how the environment shapes our brain” and the first textbook about trace metal research in autism entitled “Biometals in Autism Spectrum Disorders”

  • flag
    Jan Gründemann

    Jan Gründemann

    University of Basel,
    Basel, Switzerland

    Jan Gründemann

  • flag
    Judith Homberg

    Judith Homberg

    Radboud University, Nijmegen Medical Centre
    Nijmegen, the Netherlands

    Judith Homberg

    Judith Homberg, currently professor in Translational Neuroscience, did her PhD in 2004 at the VU Medical Center in Amsterdam. Her thesis focused on individual differences in vulnerability to drug addiction. As postdoc at the Hubrecht Institute in Utrecht she generated and characterized the first knockout rats worldwide.  After obtaining a personal grant he moved to the Radboud University Medical Center in Nijmegen to establish her own research group. Her group focusses on (serotonin-dependent) individual differences in behaviour and susceptibility to neurodevelopmental and stress-related disorders. She has strong expertise in behavioural neuroscience and bridges fundamental and clinical research. She obtained Young Investigator prizes from the European Behavioural Pharmacology Society and the International Behavioural and Neural Genetics Society, and several prestigious national and EU-funded grants. She is (co)-author of more than 180 articles, and published in amongst others Translational, Biological and Molecular Psychiatry, Cerebral Cortex, Neuroscience Biobehavioral Reviews, PNAS, Journal of Neuroscience and Nature Genetics.

  • flag
    Maja Jagodic

    Maja Jagodic

    Department of Clinical Neuroscience (CNS), Center for Molecular Medicine (CMM), Karolinska Institutet (KI),
    Stockholm, Sweden

    Maja Jagodic

    Maja Jagodic completed her MSc degree at the University of Belgrade, Serbia in Molecular Biology and Physiology specializing in Experimental Medicine in 1999. She then moved to Sweden where she obtained her PhD degree at the Karolinska Institutet studying genetic predisposition to autoimmune diseases in model organisms in 2004. After thesis defense, she spent a year at the Karolinska Institutet gaining skills in human genetics. Already towards the end of her PhD thesis, Maja became fascinated by the field of epigenetics. Epigenetic mechanisms, that orchestrate genome activity in response to environmental cues, were at that time strongly implicated in the etiology of complex inflammatory diseases but virtually unexplored. Maja was awarded a postdoctoral fellowship to study epigenetic mechanisms in cancer at the University of Cambridge, UK. In 2008, she was awarded an Assistant Professor position by the Swedish Research Council and she returned to Sweden to initiate studies of epigenetic mechanisms in Multiple Sclerosis. She was appointed a group leader position at the Department of Clinical Neuroscience at the Karolinska Institutet in 2012 and she became an Associate Professor in Experimental Medicine in 2014. Her research group continues to utilize functional genetic approaches to study mechanisms underlying chronic inflammation in the brain with a focus on Multiple Sclerosis and its experimental models.

  • flag
    Martin Kaczocha

    Martin Kaczocha

    Stony Brook University,
    NY, USA

    Martin Kaczocha

  • flag
    Liubov Kalinichenko

    Liubov Kalinichenko

    University Clinic
    Friedrich-Alexander-University of Erlangen-Nuremberg
    Erlangen, Germany

    Liubov Kalinichenko

    Dr. Liubov S. Kalinichenko graduated with the M.S. degree in pharmacy from the I.M. Sechenov First Moscow State Medical University (Russia) in 2009. In 2012, she received a Ph.D. degree in medicine from the P.K. Anokhin Institute of Normal Physiology (Russia) for her research on the role of cytokines in the regulation of oxidative and antioxidant processes in the rat brain during acute emotional stress. In 2017, she was also awarded a Ph.D. degree in neuroscience from the University Clinic Erlangen (Germany) for the investigation of the role of acid sphingomyelinase in depression/anxiety-induced alcohol addiction. This work got the Shimon Gatt Award in 2019. Since 2017, Dr. Kalinichenko is working as a postdoctoral scientist in the University Clinic Erlangen. Her primary research interests include the involvement of lipids in the mechanisms of depression-induced alcohol addiction.

  • flag
    Johannes Kirchmair

    Johannes Kirchmair

    University of Vienna,
    Vienna, Austria

    Johannes Kirchmair

  • flag
    Ewelina Knapska

    Ewelina Knapska

    Nencki Institute of Experimental Biology of Polish Academy of Sciences,
    Warsaw, Poland

    Ewelina Knapska

    Ewelina Knapska obtained MSc degrees in biology and psychology from the University of Warsaw. In 2001 she started working with Tomasz Werka and Leszek Kaczmarek, studying the heterogeneity of the amygdala in control of positive and negative emotions. After obtaining her PhD from the Nencki Institute of Experimental Biology PAS in 2006, Ewelina moved to Ann Arbor, USA for a postdoc in the laboratory of Prof. Stephen Maren at the University of Michigan, where she studied mechanisms of fear extinction. She moved back to Poland in 2008, getting a stipend from the Foundation for Polish Science and becoming an assistant professor at the Nencki Institute of Experimental Biology PAS. In 2012, she obtained habilitation (DSc) and became an associate professor and the head of the newly created Laboratory of Neurobiology of Emotions. In 2016 she received a Starting Grant from the European Research Council for studying the role of the amygdala in control of socially transferred emotions. Since 2018 she is Vice-President of Centre of Excellence for Neural Plasticity and Brain Disorders (BRAINCITY) in the Nencki Institute of Experimental Biology.

  • flag
    Michał Korostyński

    Michał Korostyński

    Maj Institute of Pharmacology Polish Academy of Sciences,
    Krakow, Poland

    Michał Korostyński

    A graduate (biotechnology) of the University of Silesia of Katowice, PhD (medical science) at the Maj Institute of Pharmacology, PAS. Currently employed at the Institute of Pharmacology, where he is conducting research in the Department of Molecular Neuropharmacology. Main research interests: gene expression regulation in the brain, genome-based treatment personalization, and genetics of complex behavioral traits and diseases. Research experience: analysis and interpretation of gene expression alterations obtained using high-throughput methods, animal and cellular models of disorders of the nervous system, and molecular profiling of psychotropic drugs. In the last few years, he has been involved in the analysis of genome-sequencing data from patients with rare diseases. He has been the principal investigator of several completed research grants and R&D projects, (co-) author of 91 publications cited 1584 times, H-index 22. He is the Field Editor of the Pharmacological Research journal.

  • flag
    Beat Lutz

    Beat Lutz

    University Medical Center of the Johannes Gutenberg, University Mainz,
    Mainz, Germany

    Beat Lutz

    Since 1997, his group has dissected the diverse functions of endocannabinoid system and the cannabinoid CB1 receptor in different cell types and organ systems, by using the Cre/loxP system in mouse. Thereby, they have made major contributions to the mechanistic understanding of this lipid signaling system in fear and anxiety circuits, in stress coping, in neuroprotection and in the regulation of the brain’s neuronal excitability, in the fine-tuned regulation of synaptic transmission and homeostatic processes, and in neural development. They found a dichotomic function of CB1 receptor in the brain’s excitatory and inhibitory neurons in signaling, synaptic transmission and behavioral regulation. They furthermore contributed to the mechanistic underpinnings on how cannabinoids and endocannabinoid degradation inhibitors employ their effects, thus, promoted our insights into the beneficial and adversive effects of cannabinoids in health and disease, an important current issue in society.

    His research fueled many other aspects of endocannabinoid research, whereby they have crucially been involved in. These studies include: olfactory perception, pain perception, spasticity in multiple sclerosis mouse models and the therapeutic potential of cannabis in this neurodegenerative disease, cannabis actions / endocannabinoid fuctions on neural developmentin endocannabinoid functions in several peripheral organs, including liver, involvement in the regulation of energy balance and feeding, discovery of CB1 receptor in mitochondria, discovery of novel endocannabinoid-like compounds, such as pepcan and lipoxin A4.

    In summary, Prof. Lutz has given numerous novel insights into this body’s signaling system, and his discoveries have had important impacts on the field of endocannabinoid research, but also on neurosciences and physiology in general.

  • flag
    Vincenzo Di Marzo

    Vincenzo Di Marzo

    Université Laval,
    Canada, Italy

    Vincenzo Di Marzo

  • flag
    Adrian Newman-Tancredi

    Adrian Newman-Tancredi

    Swansea University,
    Swansea, UK

    Adrian Newman-Tancredi

    Adrian Newman-Tancredi, PhD, DSc, is a researcher with over 25 years’ experience of neuroscience drug discovery and early development. He is Co-Founder and Chief Executive Officer of a bioscience company, Neurolixis, developing clinical-stage drugs for treatment of Parkinson’s disease and other neurological disorders. Previously, he was Director of Neurobiology drug discovery at Pierre Fabre Laboratories, identifying novel antipsychotic, antidepressant and analgesic drug candidates. Prior to Pierre Fabre, Adrian Newman-Tancredi characterized the serotonergic properties of atypical antipsychotics and antiparkinsonian drugs and investigated signal transduction of monoamine receptors at the Servier Research Institute. Dr Newman-Tancredi has published over 180 articles in peer-reviewed journals, is co-inventor on a dozen patents and serves as European Councilor for the International Society for Serotonin Research. His principal current focus is the development of the first-in-class serotonergic ‘biased agonists’ befiradol (NLX-112) and NLX-101 (F15599), having previously characterized several approved drugs, including milnacipran (Savella ®), piribedil (Trivastal ®), agomelatine (Valdoxan ®) and levomilnacipran (Fetzima ®).

  • flag
    Nicholas Pintori

    Nicholas Pintori

    University of Verone,
    Verona, Italy

    Nicholas Pintori

    Nicholas Pintori, MSc, PhD is a Post Doctoral researcher at the Neuropsychopharmacology division of the University in Cagliari. Nicholas Pintori is author of more than 10 publications in International Scientific Journals and Books, and his main research interest involves the study of the neurochemical, behavioral, and glial alterations induced by repeated exposure to synthetic cannabinoids, in particular JWH-018, and other classes of the so-called “novel psychoactive substances”. Other lines of research involve the study of the mechanism underlying the addiction, specifically the reactivation and the reconsolidation of maladaptive memories in rodents with a history of food or drug self-administration, and the study of the effect of enriched environment on food and drugs relapse in rodents.

  • flag
    Arkadiusz Piotrowski

    Arkadiusz Piotrowski

    Medical University of Gdańsk,
    Gdansk, Poland

    Arkadiusz Piotrowski

  • flag
    Rafał Płoski

    Rafał Płoski

    Medical University of Warsaw,
    Warsaw, Poland

    Rafał Płoski

  • flag
    Didier Rognan

    Didier Rognan

    Université de Strasbourg,
    Strasbourg, France

    Didier Rognan

  • flag
    Janusz Rybakowski

    Janusz Rybakowski

    Poznan University of Medical Sciences,
    Poznan, Poland

    Janusz Rybakowski

    Prof. Janusz K. Rybakowski was the Head of Department of Adult Psychiatry, Poznan University of Medical Sciences, 1995-2016, the Chairman, Department of Psychiatry, Medical Academy, Bydgoszcz, 1985-1995, the NIH Fogarty Research Fellow, Department of Psychiatry, University of Pennsylvania, Philadelphia, 1976-1977. He was the President of the Polish Psychiatric Association, 1998-2001, a Board Member of the Association of European Psychiatrists, 1998-2004, and has been a member of ten other international scientific associations.

    Prof. Rybakowski authored over 600 scientific articles on clinical psychiatry, neurobiology, and psychopharmacology, present Hirsch Index 55. He is the author of the books “The Faces of Manic-Depressive Illness” (2009) and “Lithium – the Amazing Drug in Psychiatry” (2020). He has been a member of the Editorial Board of 16 international journals. He is the only Polish psychiatrist among the top 2% scientists, according to recent report by the Stanford University and Elsevier.                                        

    In 2012,  Prof. Rybakowski received the Lifetime Achievement Award of the European Bipolar Forum, in 2015, the Lifetime Achievement Award in Biological Psychiatry of the World Federation of the Societies of Biological Psychiatry, and in 2018, the Mogens Schou scientific award of the International Society of Bipolar Disorders.

  • flag
    Tomasz Rzymski

    Tomasz Rzymski

    Ryvu Therapeutics,
    Krakow, Poland

    Tomasz Rzymski

  • flag
    Maria M. Sąsiadek

    Maria M. Sąsiadek

    Wroclaw Medical University,
    Wroclaw, Poland

    Maria M. Sąsiadek

  • flag
    Marcin Siwek

    Marcin Siwek

    Jagiellonian University Medical College,
    Krakow, Poland

    Marcin Siwek

  • flag
    Anna Sobczak

    Anna Sobczak

    Jagiellonian University,
    Krakow, Poland

    Anna Sobczak

  • flag
    Nicola Simola

    Nicola Simola

    University of Cagliari,
    Cagliari, Italy

    Nicola Simola

  • flag
    Rebecca Strawbridge

    Rebecca Strawbridge

    King’s College London,
    London, UK

    Rebecca Strawbridge

  • flag
    Róża Szweda

    Róża Szweda

    Lukasiewicz Research Network –PORT, Polish Centre of Technology Development,
    Wroclaw, Poland

    Róża Szweda

  • flag
    Łukasz Święcicki

    Łukasz Święcicki

    Institute of Psychiatry and Neurology,
    Warsaw, Poland

    Łukasz Święcicki

  • flag
    Paul Willner

    Paul Willner

    Swansea University,
    Swansea, UK

    Paul Willner

  • flag
    Jacek R. Wiśniewski

    Jacek R. Wiśniewski

    Max Planck Institute of Biochemistry,
    Martinsried, Germany

    Jacek R. Wiśniewski

  • flag
    Markus Wöhr

    Markus Wöhr

    Philipps-University of Marburg,
    Marburg, Germany

    Markus Wöhr

    Markus Wöhr, Dr. rer. nat. (PhD), is a psychologist and behavioral neuroscientist, presently working as Professor for Biological Psychology and Behavioral Pharmacology at the Faculty of Psychology and Educational Sciences, KU Leuven, Belgium. He is the head of the Social and Affective Neuroscience Research Group. Markus Wöhr has a broad background in animal behavior and translational research models for neuropsychiatric dysfunctions, with specific training and expertise in behavioral neuroscience of affective and neurodevelopmental disorders. His main research interests include neurobiological mechanisms underlying social behavior, acoustic communication through ultrasonic vocalizations, and socio-affective information processing in rodents.

Sessions

    • 09.00 – 9.10 a.m.

      Welcome message

      Chairs: Honorary Committee & Organizing Committee

    • 9.10 – 10.00 a.m.
      10.00 – 10.10 a.m. chat
      A

      Plenary lecture 1

      Inaugural lecture

      Francesco Pavone
      University of Florence, Florence, Italy
      Human brain optical mapping

      Professor Władysław Lasoń, PhD

    • 10.30 a.m.– 12.20 p.m.
      12.20 – 12.30 p.m. chat
      A

      Session 1

      Covid-19 pandemic

      Professor Marek Sanak, PhD

    • 10.30 a.m. – 12.20 p.m.
      12.20 – 12.30 p.m. chat
      B

      Session 2

      Chem- and bioinformatics in drug design

      • S.02-1
        Didier Rognan
        Université de Strasbourg, Strasbourg, France
        Designing a truly unbiased dataset for machine learning and virtual screening
      • S.02-2
        Johannes Kirchmair
        University of Vienna, Vienna, Austria
        Computational methods for flagging compounds likely to cause false outcomes in biological assays
      • S.02-3
        Tomasz Rzymski
        Ryvu Therapeutics, Krakow, Poland
        Identification of Actionable Protein Targets for Cancer Therapy by Integrated Analysis of Next-Generation Sequencing Data and High-Content Genomic Interrogation Screens

      Professor Andrzej Bojarski, PhD

    • 1.00 – 2.50 p.m.
      2.50 – 3.00 p.m. chat
      A

      Session 3

      Clinical genomics

      • S.03-1
        Rafał Płoski
        Medical University of Warsaw, Warsaw, Poland
        Whole exome and genome sequencing for discovery of novel human diseases
      • S.03-2
        Maciej Giefing
        Institute of Human Genetics Polish Academy of Sciences, Poznan, Poland
        New (epi)genetic diagnostic tools for cancer – liquid biopsy and beyond
      • S.03-3
        Maria M. Sąsiadek
        Wroclaw Medical University, Wrocław, Poland
        Multigene panel testing in oncology clinical practice – pros and cons
      • S.03-4
        Arkadiusz Piotrowski
        Medical University of Gdańsk, Gdańsk, Poland
        Somatic driver mutations in normal mammary tissue from breast cancer patients – incidental or causal?

      Michał Korostyński, PhD
      Michał Dąbrowski, PhD

    • 1.00 – 2.50 p.m.
      2.50 – 3.00 p.m. chat
      B

      Session 4

      Discovery of biomarkers in mental disorders

      • S.04-1
        Gordana Nedic Erjavec
        Ruđjer Bošković Institute, Zagreb, Croatia
        Biomarkers of schizophrenia
      • S.04-2
        Rebecca Strawbridge
        King’s College London, London, UK
        What’s the use of biomarkers for depression?
      • S.04-3
        Andreas Grabrucker
        University of Limerick, Limerick, Ireland
        Zinc deficiency and affected signalling networks as biomarkers and causative factors of Autism Spectrum Disorders

      Bernadeta Szewczyk, PhD
      Andreas Grabrucker, PhD

    • 3.30 – 5.20 p.m.
      5.20 – 5.30 p.m. chat
      A

      Session 5

      Presentations from ERC grant awardees

      • S.05-1
        Maja Jagodic
        Karolinska Institutet, Stockholm, Sweden
        Applied epigenomics: insights into the pathogenesis of Multiple Sclerosis
      • S.05-2
        Jan Gründemann
        University of Basel, Basel, Switzerland
        Imaging deep: Sensory and state coding in subcortical circuits
      • S.05-3
        Ewelina Knapska
        Nencki Institute of Experimental Biology of Polish Academy of Sciences, Warsaw, Poland
        Neuronal circuits of motivation for food rewards and social interaction

      Jan Manuel Rodriguez Parkitna, PhD

    • 9.00 a.m. – 5.30 p.m.

      Poster session

    • 9.00 – 9.10 a.m.

      Opening of the 2nd day of the CEBC

    • 9.10 – 11.00 a.m.
      11.00 – 11.10 a.m. chat
      A

      Session 6

      Perspectives for therapy of treatment-resistant depression

      • S.06-1
        Wiesław J. Cubala
        Medical University of Gdansk, Poland
        New developments in understanding mechanisms of drug resistance in the treatment of depression
      • S.06-2
        Łukasz Święcicki
        Institute of Psychiatry and Neurology, Warsaw, Poland
        Somatic therapies for treatment-resistant depression: ECT, TMS, VNS, DBS
      • S.06-3
        Paul Willner
        Swansea University, Swansea, UK
        Pharmacological and optogenetic studies on mechanisms of resistance to antidepressant drugs in animal models of treatment-resistant depression
      • S.06-4
        Adrian Newman-Tancredi
        Neurolixis Inc., Wilmington, DE 19808, USA
        Cortical 5-HT1A receptor biased agonism – a novel mechanism for effective therapy of treatment-resistant depression

      Professor Mariusz Papp, Ph.D Professor Paul Willner, PhD

    • 9.10 – 11.00 a.m.
      11.00 – 11.10 a.m. chat
      B

      Session 7

      Neuroimaging – beyond the structure

      • S.07-1
        Bogdan Draganski
        University of Lausanne, Lausanne, Switzerland
        MRI-based in vivo histology – myth or reality
      • S.07-2
        Adrian Chrobak
        Jagiellonian University Medical College, Krakow, Poland
        Time-frequency dynamics of resting state in euthymic bipolar disorder patients – a preliminary fMRI study
      • S.07-3
        Anna Ceglarek
        Jagiellonian University, Krakow, Poland
        Reduced regional homogenity after intraocular lens (IOL) implantation – restingstate fMRI study
      • S.07-4
        Anna Sobczak
        Jagiellonian University, Krakow, Poland
        Functional connectivity differences in Salient Network among euthymic bipolar disorder patients in regard to suicide risk; a preliminary fMRI study

      Professor Joanna Pera, PhD, Professor Tadeusz Marek, PhD

    • 11.30 a.m.– 12.20 p.m.
      12.20 – 12.30 p.m. chat
      A

      Plenary lecture 2

      Professor Francesco Battaglia
      Radboud University, Nijmegen, The Netherlands
      The lifetime of memories: processing and reprocessing of information in the brain

      Professor Małgorzata Filip, PhD

    • 1.00 – 2.50 p.m.
      2.50 – 3.00 p.m. chat
      A

      Session 8

      The role of serotonin in neurodevelopmental disorders

      • S.08-1
        Judith Homberg
        Radboud University, Nijmegen Medical Centre, Nijmegen, the Netherlands
        The role of serotonin in brain development and behaviour: the SSRI and efavirenz cases
      • S.08-2
        Francesca Calabrese
        University of Milan, Milan, Italy
        Stress exposure as a risk factor for the development of psychiatric disorders: a role for the serotoninergic system
      • S.08-3
        Natalia Alenina
        Max Delbruck Center for Molecular Medicine, Berlin, Germany
        Maternal and central serotonin: contribution to the early development in rodents
      • S.08-4
        Markus Wöhr
        Philipps-University of Marburg, Marburg, Germany
        Affective communication in rodents: serotonin and its modulating role in ultrasonic vocalizations

      Professor Piotr Popik, PhD
      Agnieszka Nikiforuk, PhD
      Professor Judith Homberg, PhD

    • 1.00 – 2.50 p.m.
      2.50 – 3.00 p.m. chat
      B

      Session 9

      Biological context of bipolar disorder

      • S.09-1
        Dominika Dudek
        Jagiellonian University Medical College, Krakow, Poland
        Chronobiology and social rythms in bipolar disorders
      • S.09-2
        Janusz Rybakowski
        Poznan University of Medical Sciences, Poznan, Poland
        Lithium: mechanisms of action in association with BD neurobiology
      • S.09-3
        Marcin Siwek
        Jagiellonian University Medical College, Krakow, Poland
        Biomarkers of staging in BD
      • S.09-4
        Adrian Chrobak
        Jagiellonian University Medical College, Krakow, Poland
        Neurocognitive and motor deficits in BD – neuroimaging and clinical studies
    • 3.30 – 5.30 p.m.

      Workshops

    • 9.00 a.m. – 5.30 p.m.

      Poster session

    • 9.00 – 9.10 a.m.

      Opening of the 3rd day of the CEBC

    • 9.10 – 10.00 a.m.
      10.00 – 10.10 chat
      A

      Plenary lecture 3

      Professor, Jacek R. Wiśniewski, PhD
      Max Planck Institute of Biochemistry, Martinsried, Germany
      Large scale proteomics for understanding biological systems

    • 10.20 a.m. – 12.10 p.m.
      12.10 – 12.20 p.m. chat
      A

      Session 10

      Computational personalised medicine

      • S.10-1
        Marian Bubak
        Sano Centre for Computational Medicine, Krakow and AGH University of Science and Technology, Krakow, Poland
      • S.10-2
        Róża Szweda
        Lukasiewicz Research Network –PORT, Polish Centre of Technology Development, Wrocław, Poland
        Sequence-defined polymers – a next generation data storage medium
      • S.10-3
        Zbigniew Szewczuk
        University of Wrocław, Wrocław, Poland
        Using markers in targeted diagnostics

      Marian Bubak, PhD
      Przemysław Mielczarek, PhD

    • 10.20 a.m. – 12.10 p.m.
      12.10 – 12.20 p.m. chat
      B

      Session 11

      Genes affect your risk for addiction

      • S.11-1
        Lucia Caffino
        Università degli Studi di Milano, Milano, Italy
        Effects of cocaine self-administration on neuroplastic mechanisms: evidence from rats lacking the serotonin transporter
      • S.11-2
        Judith Homberg
        Radboud University Medical Center, Nijmegen, The Netherlands
        The neural mechanisms driving the transition from regular to compulsive cocaine intake in rats lacking the serotonin transporter
      • S.11-3
        Liubov Kalinichenko
        University Clinic, Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen, Germany
        Sphingolipids in depression-induced alcoholism
      • S.11-4
        Giuseppe Giannotti
        University of Colorado Denver, Aurora, CO, USA
        Paraventricular thalamic control of opioid withdrawal and relapse

      Małgorzata Frankowska, PhD
      Irena Smaga-Maślanka, PhD
      Lucia Caffino, PhD

    • 1.00 – 1.50 p.m.
      1.50 – 2.00 p.m. chat
      A

      Plenary lecture 4

      Professor, David E. Nichols, PhD
      Purdue University College of Pharmacy, West Lafayette, LA, USA
      Psychedelic Research in the 21st Century

      Professor Krystyna Gołembiowska, PhD

    • 2.30 –4.20 p.m.
      4.20 – 4.30 p.m. chat
      A

      Session 12

      Novel views on psychoactive and additive drugs

      • S.12-1
        Kathryn A. Cunningham
        University of Texas Medical Branch, Galveston, USA
        Defining and Mining Therapeutic Targets in Psychostimulant Use Disorders
      • S.12-2
        Nicola Simola
        University of Cagliari, Cagliari, Italy
        The novel psychoactive substance methoxetamine induces persistent behavioral abnormalities and neurotoxicity: a study in rats
      • S.12-3
        Nicholas Pintori
        University of Verone, Verona, Italy
        Dopamine system dysregulation, glial cells alteration, and behavioral correlates after repeated exposure to the synthetic cannabinoid receptor agonist JWH-018
      • S.12-4
        Giulia Costa
        University of Cagliari, Cagliari, Italy
        Mechanisms and neurotransmitter systems involved in the neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) administration during adolescence.

      Professor Krystyna Gołembiowska, PhD
      Professor Kathryn A. Cunningham, PhD

    • 2.30 –4.20 p.m.
      4.20 – 4.30 p.m. chat
      B

      Session 13

      Endocannabinoid signaling in health and disease

      • S.13-1
        Vincenzo Di Marzo
        Université Laval, Canada, Italy
        Bidirectional interaction between the gut microbiome and the endocannabinoidome
      • S.13-3
        Martin Kaczocha
        Stony Brook University, NY, USA
        FABP5 as a Trans-Synaptic Carrier for Endocannabinoids
      • S.13-4
        Beat Lutz
        University Medical Center of the Johannes Gutenberg, University Mainz, Mainz, Germany
        Anandamide Signaling in Stress Coping: For Good or Bad?

      Katarzyna Starowicz – Bubak, PhD
      Professor Beat Lutz, PhD

    • 4.45 – 5.45 p.m.
      A

      Session 14

      Young scientific investigators’ session

      S.14-1-10

      Rafał Ryguła, PhD
      Karolina Noworyta, PhD

    • 5.45 – 6.00 p.m.

      Closing & Award ceremony

      Professor Małgorzata Filip, PhD
      Professor Joanna Pera, PhD

Registration

Given the circumstances, CEBC has offered the virtual congress at a significantly reduced price.

The virtual platform offered access to:

  • The full programme: live sessions, sessions with Q&A and on-demand sessions
  • Interactive e-posters with opportunities to chat with presenters,
  • Workshops (registration will be open at the end of April 2021),
  • Exhibition stands,
  • Networking opportunities.

All sessions, including ePosters and exhibition stands, will be available for

Registration fees

  • Member

    Regular
    Early Career Scientists*, Students
  • Early
    fee

    (until 1 May 2021)
    Regular:
    300 PLN
    65.82 €
    Early Career Scientists*, Students:
    150 PLN
    32.91 €
  • Standard
    fee

    (until 1 june 2021)
    Regular:
    350 PLN
    76.79 €
    Early Career Scientists*, Students:
    200 PLN
    43.88 €
  • Late
    fee

    (after 1 June 2021)
    Regular:
    400 PLN
    87.76 €
    Early Career Scientists*, Students:
    250 PLN
    54.85 €

Fees are quoted in zloty (PLN), per person. Payments in other currencies are not accepted. Please see Currency Converter to check the price in other currencies.

* Definition of an Early Career Scientist – a person who has had a doctoral degree for a period not exceeding 7 years.

Sponsors
& exhibition packages

  • >> Sponsors

    • Virtual Booth

    • Premium Plus

    • Premium

    • 3000 PLN
    • 2500 PLN
    • Logotype exposure in Sponsors / Exhibition section on the platform (no. tiles per row)
    • full size
    • 1/2 size
    • Size of thumbnail redirecting to a chosen booth (no. thumbnails per row)
    • full size
    • 1/2 size
    • Sponsor / Exhibitor badges
    • 4
    • 4
    • Company name and logo on Congress Website
    • Product brochure (documents and images)
    • Play uploaded media (single file or a playlist)
    • Communicate with visitors via text chat or a videocall
    • Promo materials for download
    • Company presentation during advertising block on a main stage
    • ✓*
    • ✓**

    * ads limited to 3 min; ** ads limited to 1 min
    Please note that VAT tax should be settled in the country where your company is registered

  • >> Exhibition

    • Virtual Booth

    • Gold

    • Silver

    • Bronze

    • 2000 PLN
    • 1500 PLN
    • 1000 PLN
    • Logotype exposure in Sponsors / Exhibition section on the platform (no. tiles per row)
    • 1/2 size
    • 1/3 size
    • 1/4 size
    • Size of thumbnail redirecting to a chosen booth (no. thumbnails per row)
    • 1/2 size
    • 1/3 size
    • 1/4 size
    • Sponsor / Exhibitor badges
    • 3
    • 2
    • 1
    • Company name and logo on Congress Website
    • Product brochure (documents and images)
    • Play uploaded media (single file or a playlist)
    • Communicate with visitors via text chat or a videocall
    • Promo materials for download

    Please note that VAT tax should be settled in the country where your company is registered

Abstract submission
& guidelines

Prior to submitting the abstract the presenting Author needs to be registered (including payment) at the Congress: www.cebc.pl. The deadline for an Abstract submission is 30th April, 2021.

RULES FOR SUBMISSION OF ABSTRACTS:

  1. Abstracts must be submitted via this website. Faxed or emailed abstracts will not be considered.
  2. All abstracts should be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. The abstract should be written using Calibri at 12 points and applying single spacing. The abstract needs to be submitted in Word document (doc, docx or rtf) format.
  3. All abstracts accepted for presentation will be published on the Congress website prior to the Congress.
  4. You may submit only 1 abstract. Presenters that are accepted for oral presentation will be permitted to give only 1 oral presentation.
  5. The abstracts will be published in the Book of Abstracts as an eBook.
  6. The abstract successfully submitted will be confirmed by e-mail.

ABSTRACT SELECTION AND PRESENTATION

The Scientific Committee will review all submitted abstracts. Notification regarding abstract acceptance and scheduling will be sent to the submitting Author. The confirmation about abstract accepted to oral presentation will be send by email before 7th may 2021.

 

British Journal<br />
of Pharmacology

British Journal
of Pharmacology

Welcome to read a special issue of British Journal of Pharmacology!

You can find several high-quality articles of our Lecturers!

Themed Issue: New discoveries and perspectives in mental and pain disorders.

Invitation to submit articles
to Pharmacological Reports

Invitation to submit articles <br />
to Pharmacological Reports

Pharmacological Reports (ISSN 1734-1140) is the official journal of Maj Institute of Pharmacology Polish Academy of Sciences published with Springer Nature.

Pharmacological Reports is an open forum for recent developments in experimental and clinical pharmacology, dealing with the action of drugs at cellular, molecular and behavioral levels.

It publishes research articles, reviews, and short communications. The journal guarantees rapid publication of accepted papers, comprised of fast acceptance and publication for articles.  It is a hybrid journal, offering the choice of open access, and is published bi-monthly.

For more information, please visit the journal’s homepage https://www.springer.com/journal/43440

­

Scientific
committee

  • Name

  • Institution

  • Country

  • Andrzej Bojarski
    Maj Institute of Pharmacology Polish Academy of Sciences
    Krakow
    Poland
    flag
  • Lucia Caffino
    Università degli Studi di Milano
    Milano
    Italy
    flag
  • Francesca Calabrese
    University of Milan
    Milan
    Italy
    flag
  • Kathryn A. Cunningham
    University of Texas Medical Branch
    Galveston
    USA
    flag
  • Michał Dąbrowski
    Nencki Institute of Experimental Biology of Polish Academy of Sciences
    Warsaw
    Poland
    flag
  • Dominika Dudek
    Jagiellonian University Medical College
    Krakow
    Poland
    flag
  • Małgorzata Filip
    Maj Institute of Pharmacology Polish Academy of Sciences
    Krakow
    Poland
    flag
  • Małgorzata Frankowska
    Maj Institute of Pharmacology Polish Academy of Sciences
    Krakow
    Poland
    flag
  • Giuseppe Giannotti
    University of Colorado Denver
    Aurora
    CO
    USA
    flag
  • Andreas Grabrucker
    University of Limerick
    Limerick
    Ireland
    flag
  • Judith Homberg
    Radboud University
    Nijmegen Medical Centre
    Nijmegen
    Netherlands
    flag
  • Martin Kaczocha
    Stony Brook University
    NY
    USA
    flag
  • Liubov Kalinichenko
    University Clinic
    Friedrich-Alexander-University of Erlangen-Nuremberg
    Erlangen
    Germany
    flag
  • Beat Lutz
    University Medical Center of the Johannes Gutenberg
    University Mainz
    Mainz
    Germany
    flag
  • Irena Nalepa
    Maj Institute of Pharmacology Polish Academy of Sciences
    Krakow
    Poland
    flag
  • Agnieszka Nikiforuk
    Maj Institute of Pharmacology Polish Academy of Sciences
    Krakow
    Poland
    flag
  • Rafał Olszanecki
    Jagiellonian University Medical College
    Krakow
    Poland
    flag
  • Mariusz Papp
    Maj Institute of Pharmacology Polish Academy of Sciences
    Krakow
    Poland
    flag
  • Jan Rodriguez Parkitna
    Maj Institute of Pharmacology Polish Academy of Sciences
    Krakow
    Poland
    flag
  • Joanna Pera
    Jagiellonian University Medical College
    Krakow
    Poland
    flag
  • Piotr Popik
    Maj Institute of Pharmacology Polish Academy of Sciences
    Krakow
    Poland
    flag
  • Edmund Przegaliński
    Maj Institute of Pharmacology Polish Academy of Sciences
    Krakow
    Poland
    flag
  • Didier Rognan
    Université de Strasbourg
    Strasbourg
    France
    flag
  • Irena Smaga-Maślanka
    Maj Institute of Pharmacology Polish Academy of Sciences
    Krakow
    Poland
    flag
  • Katarzyna Starowicz-Bubak
    Maj Institute of Pharmacology Polish Academy of Sciences
    Krakow
    Poland
    flag
  • Bernadeta Szewczyk
    Maj Institute of Pharmacology Polish Academy of Sciences
    Krakow
    Poland
    flag
  • Paul Willner
    Swansea University
    Swansea
    UK
    flag

Organizing
committee

  • flag
    Małgorzata Filip

    Małgorzata Filip

    Professor, PhD
    Function:
    Chair
    Maj Institute of Pharmacology
    Polish Academy of Sciences
  • flag
    Joanna Pera

    Joanna Pera

    Professor, PhD, MD
    Function:
    Program Chair, Guest Speakers
    Medical College
    Jagiellonian University

Remaining
organizers

  • Name

  • Function

  • Institution

  • Country

  • Email

  • Małgorzata Frankowska, PhD
    Company Exhibition, Sponsors
    Maj Institute of Pharmacology
    Polish Academy of Sciences
    Poland
    flag
  • Irena Smaga-Maślanka, PhD
    Public Relations
    Maj Institute of Pharmacology
    Polish Academy of Sciences
    Poland
    flag
  • Dawid Gawliński, PhD
    Media
    Maj Institute of Pharmacology
    Polish Academy of Sciences
    Poland
    flag
  • Karolina Wydra, PhD
    Publications
    Maj Institute of Pharmacology
    Polish Academy of Sciences
    Poland
    flag
  • Agata Faron–Górecka, PhD
    Company Exhibition, Sponsors
    Maj Institute of Pharmacology
    Polish Academy of Sciences
    Poland
    flag
  • Agata Suder
    General Secretarial Duties
    Maj Institute of Pharmacology
    Polish Academy of Sciences
    Poland
    flag
  • Kamila Piotrowska, MSc
    Guest Speaker
    Maj Institute of Pharmacology
    Polish Academy of Sciences
    Poland
    flag

Honorary Patronage

We are very pleased to announce that following persons took the honorary patronage over the 4th Central European Biomedical Congress:

  • flag
    Jacek Popiel

    Jacek Popiel

    Professor, Ph.D
    Rector of the Jagiellonian University

Honorary Committee

  • Tomasz Grodzicki

    Tomasz Grodzicki

    Professor, Ph.D, MD
    Vice Rector of Medical College
    Collegium Medicum
    Jagiellonian University
  • Władysław Lasoń

    Władysław Lasoń

    Professor, Ph.D
    Former director of the Maj Institute of Pharmacology
    Polish Academy of Sciences
  • Maciej Małecki

    Maciej Małecki

    Professor, Ph.D, MD
    Dean of the Faculty of Medicine
    Collegium Medicum
    Jagiellonian University

Sponsors